Kauffman F C, Evans R K, Thurman R G
Biochem J. 1977 Sep 15;166(3):583-92. doi: 10.1042/bj1660583.
The contents of adenine nucleotides as well as steady-state concentrations of a number of glycolytic, pentose phosphate-pathway and tricarboxylic acid-cycle intermediates were measured in extracts of livers from normal and phenobarbital-treated rats that were perfused with p-nitroanisole. Metabolites were measured in livers that were freeze-clamped during periods of maximal rates of drug metabolism. Treatment of rats with phenobarbital increased rates of p-nitroanisole O-demethylation approx. fivefold. The concentrations of lactate, xylulose 5-phosphate and ribulose 5-phosphate were increased by phenobarbital treatment, whereas that of fructose 1,6-bisphosphate declined. Perfusion of livers with p-nitroanisole produced significant increases in 6-phosphogluconate and ribulose 5-phosphate in livers from phenobarbital-treated rats, but not in livers from control rats. Treatment of rats with phenobarbital caused [NADP(+)]/[NADPH] to change in the direction of more oxidation, as calculated from measured concentrations of 6-phosphogluconate and ribulose 5-phosphate; however, the [NADP(+)]/[NADPH] ratio calculated from ;malic' enzyme was not changed. Additions of p-nitroanisole produced a reduction of NADP(+) as calculated from 6-phosphogluconate dehydrogenase activity, but did not alter the [NADP(+)]/[NADPH] ratio calculated from substrates assumed to be in equilibrium with ;malic' enzyme. Activities of both glucose 6-phosphate dehydrogenase and ;malic' enzyme were increased by phenobarbital treatment. NAD(+) became more reduced as a result of phenobarbital treatment; however, perfusion of livers with p-nitroanisole did not cause a change in the oxidation-reduction state of this nucleotide. Concentrations of adenine nucleotides in livers were not altered significantly by treatment of rats with phenobarbital; however, a significant decline in the [ATP]/[ADP] ratio occurred during mixed-function oxidation of p-nitroanisole in livers from phenobarbital-treated rats, but not in livers from normal rats. Perfusion of livers with two other substrates for mixed-function oxidation, hexobarbital and aminopyrine, produced an increase in the [NADP(+)]/[NADPH] ratio calculated from ;malic' enzyme. In contrast with livers perfused with p-nitroanisole, there was no significant change in adenine nucleotides in livers exposed to hexobarbital or aminopyrine. Addition of 2,4-dinitrophenol (25mum) to the perfusate containing aminopyrine decreased the [ATP]/[ADP] ratio and tended to prevent the oxidation of NADPH observed with aminopyrine alone. Thus in the presence of an uncoupler of oxidative phosphorylation, NADPH generation may exceed its utilization via mixed-function oxidation.
在灌注对硝基苯甲醚的正常大鼠和苯巴比妥处理大鼠的肝脏提取物中,测定了腺嘌呤核苷酸的含量以及一些糖酵解、磷酸戊糖途径和三羧酸循环中间产物的稳态浓度。在药物代谢速率达到最大值的期间,对肝脏进行冷冻钳夹,测定其中的代谢产物。用苯巴比妥处理大鼠可使对硝基苯甲醚O-去甲基化速率提高约五倍。苯巴比妥处理使乳酸、5-磷酸木酮糖和5-磷酸核酮糖的浓度升高,而1,6-二磷酸果糖的浓度下降。用对硝基苯甲醚灌注肝脏后,苯巴比妥处理大鼠的肝脏中6-磷酸葡萄糖酸和5-磷酸核酮糖显著增加,而对照大鼠的肝脏中则没有。根据所测的6-磷酸葡萄糖酸和5-磷酸核酮糖浓度计算,用苯巴比妥处理大鼠导致[NADP(+)]/[NADPH]向氧化方向变化;然而,根据“苹果酸”酶计算的[NADP(+)]/[NADPH]比值没有改变。根据6-磷酸葡萄糖酸脱氢酶活性计算,加入对硝基苯甲醚使NADP(+)减少,但没有改变根据假定与“苹果酸”酶处于平衡状态的底物计算的[NADP(+)]/[NADPH]比值。苯巴比妥处理使葡萄糖6-磷酸脱氢酶和“苹果酸”酶的活性均增加。苯巴比妥处理使NAD(+)的还原程度增加;然而,用对硝基苯甲醚灌注肝脏并没有导致该核苷酸氧化还原状态的改变。用苯巴比妥处理大鼠,肝脏中腺嘌呤核苷酸的浓度没有显著改变;然而,在苯巴比妥处理大鼠的肝脏中,对硝基苯甲醚混合功能氧化期间[ATP]/[ADP]比值显著下降,而正常大鼠的肝脏中则没有。用另外两种混合功能氧化底物己巴比妥和氨基比林灌注肝脏,根据“苹果酸”酶计算的[NADP(+)]/[NADPH]比值增加。与用对硝基苯甲醚灌注的肝脏不同,暴露于己巴比妥或氨基比林的肝脏中腺嘌呤核苷酸没有显著变化。在含有氨基比林的灌注液中加入2,4-二硝基苯酚(25μM)可降低[ATP]/[ADP]比值,并倾向于阻止单独使用氨基比林时观察到的NADPH氧化。因此,在存在氧化磷酸化解偶联剂的情况下,NADPH的生成可能超过其通过混合功能氧化的利用。